Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.47 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.42 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CDK4 | P11802 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.42 |
| ▸ | CCND1 | P24385 | 1/20 | 0.42 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | CDK7 | P50613 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3728602 | 0.81 | MAPT (0.46) | TDP1MEN1MAPTKMT2APOLB | |
| SCHEMBL3728604 | 0.81 | MAPT (0.46) | TDP1MEN1MAPTKMT2APOLB | |
| SCHEMBL5044863 | 0.81 | MEN1 (0.64) | TDP1MEN1MAPTKMT2APOLB | |
| SCHEMBL5044866 | 0.81 | MEN1 (0.64) | TDP1MEN1MAPTKMT2APOLB | |
| SCHEMBL9452106 | 0.78 | TDP1 (0.55) | TDP1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL12957569 | 0.78 | CTSB (0.60) | TDP1MEN1MAPTKMT2ANPC1 | |
| SCHEMBL6575346 | 0.78 | NPC1 (0.54) | TDP1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL6575341 | 0.78 | NPC1 (0.54) | TDP1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL17804072 | 0.75 | KMT2A (0.54) | TDP1MEN1MAPTKMT2APOLB | |
| SCHEMBL3694623 | 0.75 | MEN1 (0.73) | TDP1MEN1MAPTKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9362510-B2 | Electroluminescent metal complexes with benzotriazoles | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| WO-2008101842-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | BASF SE (CH) | 2008-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | OCIAD1, OCIAD2, OXA1L | TDP1 1996/4885MEN1 3762/4885MAPT 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.